Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
32
CPRI Quote, Financials, Valuation and Earnings
Last price:
$19.46
Seasonality move
:
10.97%
Day range:
$18.23 - $18.86
52-week range:
$11.86 - $43.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
5.95x
Volume:
2.3M
Avg. volume:
3.1M
1-year change:
-47.51%
Market cap:
$2.2B
Revenue:
$4.4B
EPS (TTM):
-$9.96
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.1B | $5.7B | $5.6B | $5.2B | $4.4B | |
| Revenue Growth (YoY) | -26.86% | 39.26% | -0.62% | -7.99% | -14.08% | |
| Cost of Revenues | $1.5B | $1.9B | $1.9B | $1.8B | $1.6B | |
| Gross Profit | $2.6B | $3.7B | $3.7B | $3.3B | $2.8B | |
| Gross Profit Margin | 63.97% | 66.22% | 66.28% | 64.58% | 63.62% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2B | $2.5B | $2.7B | $2.8B | $2.6B | |
| Other Inc / (Exp) | -$321M | -$121M | -$165M | -$644M | -$816M | |
| Operating Expenses | $2.2B | $2.7B | $2.9B | $3B | $2.8B | |
| Operating Income | $367M | $1B | $837M | $367M | $52M | |
| Net Interest Expenses | $43M | -- | $24M | $6M | -- | |
| EBT. Incl. Unusual Items | $3M | $915M | $648M | -$283M | -$727M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66M | $92M | $29M | -$54M | $452M | |
| Net Income to Company | -$63M | $823M | $619M | -$229M | -$1.2B | |
| Minority Interest in Earnings | $1M | -$1M | -$3M | -- | -$3M | |
| Net Income to Common Excl Extra Items | -$62M | $822M | $616M | -$229M | -$1.2B | |
| Basic EPS (Cont. Ops) | -$0.41 | $5.49 | $4.65 | -$1.96 | -$10.00 | |
| Diluted EPS (Cont. Ops) | -$0.41 | $5.39 | $4.60 | -$1.96 | -$10.00 | |
| Weighted Average Basic Share | $150.5M | $149.7M | $132.5M | $117M | $118.3M | |
| Weighted Average Diluted Share | $150.5M | $152.5M | $134M | $117M | $118.3M | |
| EBITDA | $579M | $1.2B | $1B | $555M | $245M | |
| EBIT | $367M | $1B | $837M | $367M | $52M | |
| Revenue (Reported) | $4.1B | $5.7B | $5.6B | $5.2B | $4.4B | |
| Operating Income (Reported) | $367M | $1B | $837M | $367M | $52M | |
| Operating Income (Adjusted) | $367M | $1B | $837M | $367M | $52M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.5B | $1.3B | $1.2B | $1B | |
| Revenue Growth (YoY) | 0.42% | 24.65% | -10.52% | -8.39% | -15.37% | |
| Cost of Revenues | $460M | $536M | $468M | $456M | $404M | |
| Gross Profit | $737M | $956M | $867M | $767M | $631M | |
| Gross Profit Margin | 61.57% | 64.08% | 64.94% | 62.72% | 60.97% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $604M | $733M | $724M | $682M | $613M | |
| Other Inc / (Exp) | -$213M | -$64M | -$154M | -$599M | -$87M | |
| Operating Expenses | $656M | $780M | $772M | $731M | $661M | |
| Operating Income | $81M | $176M | $95M | $36M | -$30M | |
| Net Interest Expenses | $4M | -- | $11M | -- | -- | |
| EBT. Incl. Unusual Items | -$136M | $119M | -$70M | -$557M | -$102M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $46M | $38M | -$37M | -$85M | $542M | |
| Net Income to Company | -$182M | $81M | -$33M | -$472M | -$644M | |
| Minority Interest in Earnings | -$1M | -- | -$1M | -- | -$1M | |
| Net Income to Common Excl Extra Items | -$183M | $81M | -$34M | -$472M | -$645M | |
| Basic EPS (Cont. Ops) | -$1.21 | $0.55 | -$0.28 | -$4.03 | -$5.44 | |
| Diluted EPS (Cont. Ops) | -$1.21 | $0.54 | -$0.28 | -$4.03 | -$5.44 | |
| Weighted Average Basic Share | $151.1M | $146M | $123.3M | $117.2M | $118.6M | |
| Weighted Average Diluted Share | $151.1M | $148.5M | $124.9M | $117.2M | $118.6M | |
| EBITDA | $133M | $223M | $154M | $85M | $18M | |
| EBIT | $81M | $176M | $106M | $36M | -$30M | |
| Revenue (Reported) | $1.2B | $1.5B | $1.3B | $1.2B | $1B | |
| Operating Income (Reported) | $81M | $176M | $95M | $36M | -$30M | |
| Operating Income (Adjusted) | $81M | $176M | $106M | $36M | -$30M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.1B | $5.7B | $5.6B | $5.2B | $4.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.5B | $1.9B | $1.9B | $1.8B | $1.6B | |
| Gross Profit | $2.6B | $3.7B | $3.7B | $3.3B | $2.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2B | $2.5B | $2.7B | $2.8B | $2.6B | |
| Other Inc / (Exp) | -$321M | -$121M | -$165M | -$644M | -$816M | |
| Operating Expenses | $2.2B | $2.7B | $2.9B | $3B | $2.8B | |
| Operating Income | $367M | $1B | $837M | $367M | $52M | |
| Net Interest Expenses | $43M | -- | $24M | $6M | -- | |
| EBT. Incl. Unusual Items | $3M | $915M | $648M | -$283M | -$727M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66M | $92M | $29M | -$54M | $452M | |
| Net Income to Company | -$63M | $823M | $619M | -$229M | -$1.2B | |
| Minority Interest in Earnings | $1M | -$1M | -$3M | -- | -$3M | |
| Net Income to Common Excl Extra Items | -$62M | $822M | $616M | -$229M | -$1.2B | |
| Basic EPS (Cont. Ops) | -$0.42 | $5.46 | $4.52 | -$1.96 | -$9.96 | |
| Diluted EPS (Cont. Ops) | -$0.43 | $5.36 | $4.47 | -$1.97 | -$9.96 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $575M | $1.2B | $1B | $555M | $245M | |
| EBIT | $363M | $1B | $844M | $367M | $52M | |
| Revenue (Reported) | $4.1B | $5.7B | $5.6B | $5.2B | $4.4B | |
| Operating Income (Reported) | $367M | $1B | $837M | $367M | $52M | |
| Operating Income (Adjusted) | $363M | $1B | $844M | $367M | $52M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.6B | $5.2B | $4.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9B | $1.9B | $1.8B | $1.6B | -- | |
| Gross Profit | $3.7B | $3.7B | $3.3B | $2.8B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5B | $2.7B | $2.8B | $2.6B | -- | |
| Other Inc / (Exp) | -$121M | -$165M | -$644M | -$816M | -- | |
| Operating Expenses | $2.7B | $2.9B | $3B | $2.8B | -- | |
| Operating Income | $1B | $837M | $367M | $52M | -- | |
| Net Interest Expenses | $1M | $28M | $12M | -- | -- | |
| EBT. Incl. Unusual Items | $915M | $648M | -$283M | -$727M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $92M | $29M | -$54M | $452M | -- | |
| Net Income to Company | $823M | $619M | -$229M | -$1.2B | -- | |
| Minority Interest in Earnings | -$1M | -$3M | -- | -$3M | -- | |
| Net Income to Common Excl Extra Items | $822M | $616M | -$229M | -$1.2B | -- | |
| Basic EPS (Cont. Ops) | $5.46 | $4.52 | -$1.96 | -$9.96 | -- | |
| Diluted EPS (Cont. Ops) | $5.36 | $4.47 | -$1.97 | -$9.96 | -- | |
| Weighted Average Basic Share | $598.9M | $530.1M | $468.1M | $473M | -- | |
| Weighted Average Diluted Share | $610M | $536M | $471.2M | $473.3M | -- | |
| EBITDA | $1.2B | $1B | $555M | $245M | -- | |
| EBIT | $1B | $844M | $367M | $52M | -- | |
| Revenue (Reported) | $5.7B | $5.6B | $5.2B | $4.4B | -- | |
| Operating Income (Reported) | $1B | $837M | $367M | $52M | -- | |
| Operating Income (Adjusted) | $1B | $844M | $367M | $52M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $232M | $169M | $249M | $199M | $166M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $412M | $461M | $412M | $342M | $295M | |
| Inventory | $736M | $1.1B | $1.1B | $862M | $869M | |
| Prepaid Expenses | $144M | $101M | $127M | $109M | $126M | |
| Other Current Assets | $36M | $61M | $48M | $50M | $30M | |
| Total Current Assets | $1.5B | $1.9B | $1.9B | $1.6B | $1.5B | |
| Property Plant And Equipment | $2B | $1.8B | $1.9B | $2B | $1.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.5B | $1.4B | $1.3B | $1.1B | $688M | |
| Other Intangibles | $2B | $1.8B | $1.7B | $1.4B | $1.1B | |
| Other Long-Term Assets | $178M | $250M | $226M | $212M | $162M | |
| Total Assets | $7.5B | $7.5B | $7.3B | $6.7B | $5.2B | |
| Accounts Payable | $512M | $555M | $475M | $352M | $485M | |
| Accrued Expenses | $194M | $279M | $267M | $241M | $235M | |
| Current Portion Of Long-Term Debt | $123M | $29M | $5M | $462M | $24M | |
| Current Portion Of Capital Lease Obligations | $447M | $414M | $429M | $400M | $350M | |
| Other Current Liabilities | $161M | $152M | $137M | $132M | $121M | |
| Total Current Liabilities | $1.6B | $1.6B | $1.5B | $1.7B | $1.3B | |
| Long-Term Debt | $1.2B | $1.1B | $1.8B | $1.3B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.3B | $4.9B | $5.4B | $5.1B | $4.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $56M | $194M | $147M | $161M | $57M | |
| Common Equity | $2.2B | $2.6B | $1.8B | $1.6B | $368M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1M | -$1M | $1M | $1M | $4M | |
| Total Equity | $2.2B | $2.6B | $1.8B | $1.6B | $372M | |
| Total Liabilities and Equity | $7.5B | $7.5B | $7.3B | $6.7B | $5.2B | |
| Cash and Short Terms | $232M | $169M | $249M | $199M | $166M | |
| Total Debt | $1.3B | $1.2B | $1.8B | $1.7B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $232M | $169M | $249M | $199M | $166M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $412M | $461M | $412M | $342M | $295M | |
| Inventory | $736M | $1.1B | $1.1B | $862M | $869M | |
| Prepaid Expenses | $144M | $101M | $127M | $109M | $126M | |
| Other Current Assets | $36M | $61M | $48M | $50M | $30M | |
| Total Current Assets | $1.5B | $1.9B | $1.9B | $1.6B | $1.5B | |
| Property Plant And Equipment | $2B | $1.8B | $1.9B | $2B | $1.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.5B | $1.4B | $1.3B | $1.1B | $688M | |
| Other Intangibles | $2B | $1.8B | $1.7B | $1.4B | $1.1B | |
| Other Long-Term Assets | $178M | $250M | $226M | $212M | $162M | |
| Total Assets | $7.5B | $7.5B | $7.3B | $6.7B | $5.2B | |
| Accounts Payable | $512M | $555M | $475M | $352M | $485M | |
| Accrued Expenses | $194M | $279M | $267M | $241M | $235M | |
| Current Portion Of Long-Term Debt | $123M | $29M | $5M | $462M | $24M | |
| Current Portion Of Capital Lease Obligations | $447M | $414M | $429M | $400M | $350M | |
| Other Current Liabilities | $161M | $152M | $137M | $132M | $121M | |
| Total Current Liabilities | $1.6B | $1.6B | $1.5B | $1.7B | $1.3B | |
| Long-Term Debt | $1.2B | $1.1B | $1.8B | $1.3B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.3B | $4.9B | $5.4B | $5.1B | $4.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $56M | $194M | $147M | $161M | $57M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1M | -$1M | $1M | $1M | $4M | |
| Total Equity | $2.2B | $2.6B | $1.8B | $1.6B | $372M | |
| Total Liabilities and Equity | $7.5B | $7.5B | $7.3B | $6.7B | $5.2B | |
| Cash and Short Terms | $232M | $169M | $249M | $199M | $166M | |
| Total Debt | $1.3B | $1.2B | $1.8B | $1.7B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$63M | $823M | $619M | -$229M | -$1.2B | |
| Depreciation & Amoritzation | $212M | $193M | $179M | $188M | $193M | |
| Stock-Based Compensation | $71M | $85M | $78M | $72M | $59M | |
| Change in Accounts Receivable | -$52M | -$78M | $50M | $27M | $50M | |
| Change in Inventories | $145M | -$386M | $13M | $175M | -$3M | |
| Cash From Operations | $624M | $704M | $771M | $309M | $281M | |
| Capital Expenditures | $111M | $131M | $226M | $189M | $128M | |
| Cash Acquisitions | -- | -- | -- | -- | -$9M | |
| Cash From Investing | -$124M | $58M | $183M | -$135M | -$53M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.4B | $945M | $4.1B | $1.7B | $3.3B | |
| Long-Term Debt Repaid | -$3.3B | -$1.1B | -$3.5B | -$1.8B | -$3.5B | |
| Repurchase of Common Stock | -$1M | -$661M | -$1.4B | -$107M | -$4M | |
| Other Financing Activities | -$4M | $31M | -$5M | -- | -$20M | |
| Cash From Financing | -$870M | -$800M | -$776M | -$208M | -$242M | |
| Beginning Cash (CF) | $592M | $234M | $172M | $256M | $205M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$370M | -$38M | $178M | -$34M | -$14M | |
| Ending Cash (CF) | $234M | $172M | $256M | $205M | $175M | |
| Levered Free Cash Flow | $513M | $573M | $545M | $120M | $153M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$182M | $81M | -$33M | -$472M | -$644M | |
| Depreciation & Amoritzation | $52M | $47M | $48M | $49M | $48M | |
| Stock-Based Compensation | $18M | $16M | $18M | $7M | $10M | |
| Change in Accounts Receivable | -$9M | $6M | $2M | -- | -$5M | |
| Change in Inventories | $46M | -$129M | $137M | $141M | $35M | |
| Cash From Operations | $79M | -$9M | $155M | $44M | -$161M | |
| Capital Expenditures | $26M | $46M | $58M | $50M | $27M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$27M | $84M | -$58M | $4M | $15M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $167M | $444M | $628M | $428M | $1.5B | |
| Long-Term Debt Repaid | -$237M | -$286M | -$353M | -$520M | -$1.5B | |
| Repurchase of Common Stock | -- | -$301M | -$400M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$18M | |
| Cash From Financing | -$67M | -$137M | -$125M | -$92M | -$30M | |
| Beginning Cash (CF) | $229M | $264M | $284M | $255M | $365M | |
| Foreign Exchange Rate Adjustment | $20M | -$30M | -- | -$6M | -$14M | |
| Additions / Reductions | -$15M | -$62M | -$28M | -$44M | -$176M | |
| Ending Cash (CF) | $234M | $172M | $256M | $205M | $175M | |
| Levered Free Cash Flow | $53M | -$55M | $97M | -$6M | -$188M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$63M | $823M | $619M | -$229M | -$1.2B | |
| Depreciation & Amoritzation | $212M | $193M | $179M | $188M | $193M | |
| Stock-Based Compensation | $71M | $85M | $78M | $72M | $59M | |
| Change in Accounts Receivable | -$52M | -$78M | $50M | $27M | $50M | |
| Change in Inventories | $145M | -$386M | $13M | $175M | -$3M | |
| Cash From Operations | $624M | $704M | $771M | $309M | $281M | |
| Capital Expenditures | $111M | $131M | $226M | $189M | $128M | |
| Cash Acquisitions | -- | -- | -- | -- | -$9M | |
| Cash From Investing | -$124M | $58M | $183M | -$135M | -$53M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.4B | $945M | $4.1B | $1.7B | $3.3B | |
| Long-Term Debt Repaid | -$3.3B | -$1.1B | -$3.5B | -$1.8B | -$3.5B | |
| Repurchase of Common Stock | -$1M | -$661M | -$1.4B | -$107M | -$4M | |
| Other Financing Activities | -$4M | $31M | -$5M | -- | -- | |
| Cash From Financing | -$870M | -$800M | -$776M | -$208M | -$242M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$370M | -$38M | $178M | -$34M | -$14M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $513M | $573M | $545M | $120M | $153M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $823M | $619M | -$229M | -$1.2B | -- | |
| Depreciation & Amoritzation | $193M | $179M | $188M | $193M | -- | |
| Stock-Based Compensation | $85M | $78M | $72M | $59M | -- | |
| Change in Accounts Receivable | -$78M | $50M | $27M | $50M | -- | |
| Change in Inventories | -$386M | $13M | $175M | -$3M | -- | |
| Cash From Operations | $704M | $771M | $309M | $281M | -- | |
| Capital Expenditures | $131M | $226M | $189M | $128M | -- | |
| Cash Acquisitions | -- | -- | -- | -$9M | -- | |
| Cash From Investing | $58M | $183M | -$135M | -$53M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $945M | $4.1B | $1.7B | $3.3B | -- | |
| Long-Term Debt Repaid | -$1.1B | -$3.5B | -$1.8B | -$3.5B | -- | |
| Repurchase of Common Stock | -$661M | -$1.4B | -$107M | -$4M | -- | |
| Other Financing Activities | $31M | -$5M | -- | -$20M | -- | |
| Cash From Financing | -$800M | -$776M | -$208M | -$242M | -- | |
| Beginning Cash (CF) | $1.1B | $899M | $995M | $983M | -- | |
| Foreign Exchange Rate Adjustment | -$24M | -$94M | -$17M | -$16M | -- | |
| Additions / Reductions | -$38M | $178M | -$34M | -$14M | -- | |
| Ending Cash (CF) | $1B | $983M | $944M | $953M | -- | |
| Levered Free Cash Flow | $573M | $545M | $120M | $153M | -- | |
Get CPRI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CPRI
Sector
P/E ratio
--
16.92x
PEG ratio
0.00x
0.17x
P/B ratio
5.95x
1.42x
Price / LTM sales
0.50x
0.68x
Growth Metrics
CPRI
Sector
Revenue growth
-15.37%
0.64%
Earnings growth
-74.03%
-1.02%
Revenue (5-year growth)
-4.36%
3.61%
Earnings forecast
$0.12
$0.24
Profitability
CPRI
Sector
Profitability FY 2024
$2.8B
$456.7M
Return on invested capital
-41.52%
4.58%
Return on assets
-18.93%
2.72%
Return on equity
-96.71%
6.7%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Nov
7
Estimated Next Earnings Date
Aug
27
Balance Sheet
CPRI
Sector
Total cash
$166M
$139.6M
Short term investments
--
$46.8M
Total assets
$5.2B
$1.4B
Long term debt
$1.5B
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
